Infective, neoplastic, and homeostatic sequelae of the loss of perforin function in humans

Advances in Experimental Medicine and Biology

Volumn 601, Issue , 2007, Pages 235-242

  Trapani, Joseph A ^a   Voskoboinik, Ilia ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; PERFORIN; PORE FORMING CYTOTOXIC PROTEIN; UNCLASSIFIED DRUG;

ALLELE; ANIMAL; BIOLOGICAL MODEL; BIOSYNTHESIS; CYTOPLASM; CYTOTOXIC T LYMPHOCYTE; GENETIC POLYMORPHISM; GENETICS; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; METABOLISM; MOUSE; NATURAL KILLER CELL; NEOPLASM; PHYSIOLOGY; REVIEW; SEPSIS;

ALLELES; ANIMALS; CYTOPLASM; HUMANS; IMMUNE SYSTEM; KILLER CELLS, NATURAL; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MEMBRANE GLYCOPROTEINS; MICE; MODELS, BIOLOGICAL; NEOPLASMS; POLYMORPHISM, GENETIC; PORE FORMING CYTOTOXIC PROTEINS; SEPSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 34848822311     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-0-387-72005-0_24     Document Type: Conference Paper

References (35)

1. Bird, C.H., Sun, J., Ung, K., Karambalis, D., Whisstock, J.C., Trapani, J.A. and Bird, P.I. (2005) Cationic sites on granzyme B contribute to cytotoxicity by promoting its uptake into target cells. Mol. Cell. Biol. 25, 7854-7867.
2. Busiello, R., Adriani, M., Locatelli, F., Galgani, M., Fimiani, G., Clementi, R., Ursini, M.V., Racioppi, L. and Pignata, C. (2004) Atypical features of familial hemophagocytic lymphohistiocytosis. Blood 103, 4610-4612.
3. Clementi, R., Emmi, L., Maccario, R., Liotta, F., Moretta, L., Danesino, C. and Arico, M. (2002) Adult onset and atypical presentation of hemophagocytic lymphohistiocytosis in siblings carrying PRF1 mutations. Blood 100, 2266-2267.
4. Clementi, R., Locatelli, F., Dupre, L., Garaventa, A., Emmi, L., Bregni, M., Cefalo, G., Moretta, A., Danesino, C., Comis, M., Pession, A., Ramenghi, U., Maccario, R., Arico, M. and Roncarolo, M.G. (2005) A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood 105, 4424-4428.
5. Clementi, R., Chiocchetti, A., Cappellano, G., Cerutti, E., Ferretti, M., Orilieri, E., Dianzani, I., Ferrarini, M., Bregni, M., Danesino, C., Bozzi, V., Putti, M.C., Cerutti, F., Cometa, A., Locatelli, F., Maccario, R., Ramenghi, U. and Dianzani, U. (2006) Variations of the perforin gene in patients with autoimmunity/lymphoproliferation and defective fas function. Blood 108, 3079-3084.
6. Henter, J.I., Arico, M., Elinder, G., Imashuku, S. and Janka, G. (1998) Familial hemophagocytic lymphohistiocytosis. Primary hemophagocytic lymphohistiocytosis. Hematol. Oncol. Clin. North. Am. 12, 417-433.
7. Henter, J.I., Samuelsson-Horne, A., Arico, M., Egeler, R.M., Elinder, G., Filipovich, A.H., Gadner, H., Imashuku, S., Komp, D., Ladisch, S., Webb, D. and Janka, G. (2002) Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100, 2367-2373.
8. Hwang, J.Y., Ohira, T., Hirono, I. and Aoki, T. (2004). A pore-forming protein, perforin, from a non-mammalian organism, Japanese flounder, Paralichthys olivaceus. Immunogenetics 56, 360-367.
9. Janka, G.E. (1989) Familial hemophagocytic lymphohistiocytosis: Diagnostic problems and differential diagnosis. Pediatr. Hematol. Oncol. 6, 219-225.
10. Janka, G. and Zur Stadt, U. (2005) Familial and acquired hemophagocytic lymphohistiocytosis. Hematology (Am. Soc. Hematol. Educ. Program) 82-88.
11. Kagi, D., Ledermann, B., Burki, K., Seiler, P., Odermatt, B., Olsen, K.J., Podack, E.R., Zinkernagel, R.M. and Hengartner, H. (1994) Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31-37.
12. Katano, H., Ali, M.A., Patera, A.C., Catalfamo, M., Jaffe, E.S., Kimura, H., Dale, J.K., Straus, S.E. and Cohen, J.I. (2004) Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation. Blood 103, 1244-1252.
13. Katano, H. and Cohen, J.I. (2005) Perforin and lymphohistiocytic proliferative disorders. Br. J. Haematol. 128, 739-750.
14. Lichtenheld, M.G., Olsen, K.J., Lu, P., Lowrey, D.M., Hameed, A., Hengartner, H. and Podack, E.R. (1988) Structure and function of human perforin. Nature 335, 448-451.
15. Lieberman, J. and Fan, Z. (2003) Nuclear war: The granzyme A-bomb. Curr. Opin. Immunol. 15, 553-559.
16. Liu, C.C., Walsh, C.M. and Young, J.D. (1995) Perforin: Structure and function. Immunol. Today 16, 194-201.
17. Mancebo, E., Allende, L.M., Guzman, M., Paz-Artal, E., Gil, J., Urrea-Moreno, R., Fernandez-Cruz, E., Gaya, A., Calvo, J., Arbos, A., Duran, M.A., Canet, R., Balanzat, J., Udina, M.A. and Vercher, F.J. (2006) Familial hemophagocytic lymphohistiocytosis in an adult patient homozygous for A91V in the perforin gene, with tuberculosis infection. Haematologica 91, 1257-1260.
18. Mehta, P.A., Davies, S.M., Kumar, A., Devidas, M., Lee, S., Zamzow, T., Elliott, J., Villanueva, J., Pullen, J., Zewge, Y. and Filipovich, A. (2006) Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group. Leukemia 20, 1539-1541.
19. Menager, M.M., Menasche, G., Romao, M., Knapnougel, P., Ho, C.H., Garfa, M., Raposo, G., Feldmann, J., Fischer, A. and De Saint Basile, G. (2007) Secretory cytotoxic granule maturation and exocytosis require the effector protein hMunc13-4. Nat. Immunol. 8, 257-267.
20. Rochel, N. and Cowan, J. (1996) Negative cooperativity exhibited by the lytic amino-terminal domain of human perforin: Implications for perforin-mediated cell lysis. Chem. Biol. 3, 31-36.
21. Santoro, A., Cannella, S., Trizzino, A., Lo Nigro, L., Corsello, G. and Arico, M. (2005) A single amino acid change A91V in perforin: A novel, frequent predisposing factor to childhood acute lymphoblastic leukemia? Haematologica 90, 697-698.
22. Shiver, J.W. and Henkart, P.A. (1991) A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene. Cell 64, 1175-1181.
23. Smyth, M.J., Kelly, J.M., Sutton, V.R., Davis, J.E., Browne, K.A., Sayers, T. and Trapani, J.A. (2001) Unlocking the secrets of cytotoxic granule proteins. J. Leukoc. Biol. 70, 18-29.
24. Stepp, S.E., Dufourcq-Lagelouse, R., Le Deist, F., Bhawan, S., Certain, S., Mathew, P.A., Henter, J.I., Bennett, M., Fischer, A., De Saint Basile, G. and Kumar, V. (1999) Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286, 1957-1959.
25. Street, S.E., Hayakawa, Y., Zhan, Y., Lew, A.M., MacGregor, D., Jamieson, A.M., Diefenbach, A., Yagita, H., Godfrey, D.I. and Smyth, M.J. (2004) Innate immune surveillance of spontaneous B cell lymphomas by natural killer cells and gammadelta T cells. J. Exp. Med. 199, 879-884.
26. Trambas, C., Gallo, F., Pende, D., Marcenaro, S., Moretta, L., De Fusco, C., Santoro, A., Notarangelo, L., Arico, M. and Griffiths, G.M. (2005) A single amino acid change, A91V, leads to conformational changes that can impair processing to the active form of perforin. Blood 106, 932-937.
27. Trapani, J.A. and Smyth, M.J. (2002) Functional significance of the perforin/granzyme cell death pathway. Nat. Rev. Immunol. 2, 735-747.
28. Trapani, J.A. and Sutton, V.R. (2003) Granzyme B: Pro-apoptotic, antiviral and antitumor functions. Curr. Opin. Immunol. 15, 533-543.
29. Uellner, R., Zvelebil, M.J., Hopkins, J., Jones, J., MacDougall, L.K., Morgan, B.P., Podack, E., Waterfield, M.D. and Griffiths, G.M. (1997) Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain. EMBO J. 16, 7287-7296.
30. Voskoboinik, I., Thia, M.-C., De Bono, A., Browne, K., Cretney, E., Jackson, J.T., Darcy, P. K., Jane, S.M., Smyth, M.J. and Trapani, J.A. (2004) The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene. J. Exp. Med. 200, 811-816.
31. Voskoboinik, I., Thia, M.C., Fletcher, J., Ciccone, A., Browne, K., Smyth, M.J. and Trapani, J.A. (2005a) Calcium-dependent plasma membrane binding and cell lysis by perforin are mediated through its C2 domain: A critical role for aspartate residues 429, 435, 483, and 485 but not 491. J. Biol. Chem. 280, 8426-8234.
32. Voskoboinik, I., Thia, M.C. and Trapani, J.A. (2005b) A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood 105, 4700-4706.
33. Voskoboinik, I. and Trapani, J.A. (2006) Addressing the mysteries of perforin function. Immunol. Cell. Biol. 84, 66-71.
34. Waterhouse, N., Sedelies, K., Browne, K., Wowk, M., Newbold, A., Sutton, V., Clarke, C.J., Oliaro, J., Lindemann, R.K., Bird, P., Johnstone, R.W. and Trapani, J.A. (2005) A central role for Bid in granzyme B-induced apoptosis. J. Biol. Chem. 280, 4476-4482.
35. Zur Stadt, U., Beutel, K., Weber, B., Kabisch, H., Schneppenheim, R., Janka, G., Busiello, R., Galgani, M., De Fusco, C., Poggi, V., Adriani, M., Racioppi, L. and Pignata, C. (2004) A91V is a polymorphism in the perforin gene not causative of an FHLH phenotype. Blood 104, 1909-1910.